Skip to main content
Equibles

STEMPOINT CAPITAL LP

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1952142 NEW YORK, NY
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,276
-$40,911 QoQ
Shares Held
616,749
0.0% QoQ
Ownership
1.39%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 48 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STEMPOINT CAPITAL LP holds $524,439,182 across 65 Biotechnology names. VTGN ranks #65 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TNGX
Tango Therapeutics, Inc.
 1,223,019 $38,231,573
2 ABVX
Abivax S.A.
 283,657 $37,800,131
3 RVMD
Revolution Medicines, Inc.
 159,943 $29,954,125
4 ERAS
Erasca, Inc.
 1,565,913 $28,687,526
5 TYRA
Tyra Biosciences, Inc.
 632,754 $20,210,162
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 200,851 $19,578,955
7 ELVN
Enliven Therapeutics, Inc.
 346,914 $17,605,885
8 MLYS
Mineralys Therapeutics, Inc.
 602,686 $16,260,468

All Filings in VTGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,276 616,749
2026-03-31 $58,187 616,749
2025-12-31 $407,054 616,749
2025-09-30 $8,834,830 2,488,685
2025-06-30 $4,826,508 2,413,254
2025-03-31 $5,916,384 2,366,554
2024-12-31 $6,869,050 2,328,492
2024-09-30 $5,558,843 1,846,792
2024-06-30 $6,433,064 1,848,582
2024-03-31 $9,760,512 1,848,582
2023-12-31 $9,201,534 1,790,182